The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields.
Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK) are the prominent players operating in the metagenomic sequencing market.
To know about the assumptions considered for the study download the pdf brochure
Illumina (US) is the leading player in the metagenomic sequencing market, accounting for the largest share of the market in 2020. This is attributed to its robust product offerings and NGS services. The company’s product segment includes a wide range of sequencing, genotyping, gene expression, and molecular diagnostic platforms, consumables, and services that run on SBS technology. In the past three years, Illumina has launched several products in the market, including the NovaSeqT 6000 v1.5 Reagent Kit, TruSight Software Suite, NextSeq 1000, and NextSeq 2000. To ensure continuous product development, the company invests a significant amount of its revenue on R&D. It also focuses on agreements with leading players to co-develop advanced technologies and strengthen its research & commercialization capabilities. In the past three years, Illumina has entered into agreements with Helix OpCo, LLC (US), Roche (Switzerland), and QIAGEN (Netherlands).
Thermo Fisher Scientific (US) held the second position in the metagenomic sequencing market in 2020. The company’s NGS sequencers run on Ion Semiconductor sequencing technology. Thermo Fisher will continue to have a strong market position owing to its robust platforms and consumables offerings. The company also has a significant geographic presence. It adopts organic and inorganic strategies such as collaborations, partnerships, and product launches to strengthen its market position. For instance, in September 2021, it codeveloped NGS-based companion diagnostics with AstraZeneca.
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE